SCHEMBL2916148

SCHEMBL2916148

O=c1cc(N2CCN(Cc3cc(Br)cc(Br)c3O)CC2)nc[nH]1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GFER P55789 1/20 0.53
LMNA P02545 5/20 0.50
GAA P10253 4/20 0.41
ACHE P22303 2/20 0.39
KDM4E B2RXH2 4/20 0.38
RAB9A P51151 4/20 0.38
TP53 P04637 3/20 0.38
NPSR1 Q6W5P4 3/20 0.38
KMT2A Q03164 2/20 0.38
CYP1A2 P05177 2/20 0.38
HSP90AA1 P07900 2/20 0.38
CYP2D6 P10635 2/20 0.38
ALOX15 P16050 2/20 0.38
CYP2C19 P33261 2/20 0.38
MEN1 O00255 1/20 0.38
HIF1A Q16665 1/20 0.38
MAPT P10636 4/20 0.37
DRD4 P21917 1/20 0.36
SMN1; SMN2 Q16637 4/20 0.36
MAPK1 P28482 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2920974 0.89 LMNA (0.40) GFERLMNAACHEKDM4ERAB9A
SCHEMBL2927617 0.88 GAA (0.58) GFERLMNAGAAKDM4ERAB9A
SCHEMBL2927242 0.85 KDM4E (0.41) GFERLMNAGAAKDM4ERAB9A
SCHEMBL2920503 0.84 TSHR (0.55) GFERLMNAACHEKDM4EKMT2A
SCHEMBL2927721 0.80 CYP2A13 (0.45) LMNAKDM4ERAB9AKMT2AMEN1
SCHEMBL2926479 0.80 TSHR (0.39) GFERLMNAKMT2ASMN1; SMN2TSHR
SCHEMBL2926143 0.80 KDM4E (0.36) LMNAGAAKDM4ERAB9ANPSR1
SCHEMBL2918950 0.80 LMNA (0.51) LMNAACHEKDM4ERAB9ANPSR1
SCHEMBL2926813 0.79 KDM4E (0.55) LMNAKDM4ETP53KMT2AMEN1
SCHEMBL2921494 0.78 MAPT (0.40) LMNAGAAACHEKDM4ERAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2231619-B1 INHIBITORS OF STEAROYL-COA DESATURASE HOFFMANN LA ROCHE (CH) 2014-11-26 EP claimed
EP-2231619-A1 INHIBITORS OF STEAROYL-COA DESATURASE F. Hoffmann-La Roche AG (CH) 2010-09-29 EP claimed
WO-2009074487-A1 INHIBITORS OF STEAROYL-COA DESATURASE F. HOFFMANN-LA ROCHE AG (CH) 2009-06-18 WO claimed
US-9358250-B2 Methods of using SCD1 antagonists GENENTECH, INC. (US) 2016-06-07 US disclosed
US-9358250-B2 Methods of using SCD1 antagonists GENENTECH, INC. (US) 2016-06-07 US disclosed
EP-2231619-B1 INHIBITORS OF STEAROYL-COA DESATURASE HOFFMANN LA ROCHE (CH) 2014-11-26 EP disclosed
EP-2231619-B1 INHIBITORS OF STEAROYL-COA DESATURASE HOFFMANN LA ROCHE (CH) 2014-11-26 EP disclosed
EP-2231619-A1 INHIBITORS OF STEAROYL-COA DESATURASE F. Hoffmann-La Roche AG (CH) 2010-09-29 EP disclosed
US-7652013-B2 Inhibitors of stearoyl-CoA desaturase HOFFMAN-LA ROCHE INC. (US) 2010-01-26 US disclosed
US-7652013-B2 Inhibitors of stearoyl-CoA desaturase HOFFMAN-LA ROCHE INC. (US) 2010-01-26 US disclosed
US-7652013-B2 Inhibitors of stearoyl-CoA desaturase HOFFMAN-LA ROCHE INC. (US) 2010-01-26 US disclosed
WO-2009074487-A1 INHIBITORS OF STEAROYL-COA DESATURASE F. HOFFMANN-LA ROCHE AG (CH) 2009-06-18 WO disclosed
WO-2009074487-A1 INHIBITORS OF STEAROYL-COA DESATURASE F. HOFFMANN-LA ROCHE AG (CH) 2009-06-18 WO disclosed
US-20090149466-A1 INHIBITORS OF STEAROYL-COA DESATURASE GILLESPIE PAUL 2009-06-11 US disclosed
US-20090149466-A1 INHIBITORS OF STEAROYL-COA DESATURASE GILLESPIE PAUL 2009-06-11 US disclosed
US-20090149466-A1 INHIBITORS OF STEAROYL-COA DESATURASE GILLESPIE PAUL 2009-06-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090149466-A1 INHIBITORS OF STEAROYL-COA DESATURASE SCD, SCD5, FADS2 GFER 853/4885LMNA 2327/4885GAA 279/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.